Improving the management of genital herpes

Hospital Practice

Volumn 34, Issue 2, 1999, Pages 41-49

  Sacks, Stephen L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE TRANSMISSION; FEMALE; GENITAL HERPES; HEALTH SURVEY; HERPES SIMPLEX VIRUS; HUMAN; MALE; RECURRENCE RISK; RISK FACTOR; SEROCONVERSION; VIRUS INFECTION; VIRUS SHEDDING;

EID: 0033558067     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.3810/hp.1999.02.129     Document Type: Article

References (7)

1. Diaz-Mitoma F et al: Oral famciclovir for the suppression of recurrent genital herpes. JAMA 280:887, 1998
2. Fleming DT et al: Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 337:1105, 1997
3. Reitano M et al: Valacyclovir for the suppression of recurrent genital herpes simplex virus infection: A large-scale, dose range-finding study. J Infect Dis 178:603, 1998
4. Sacks SL et al: Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. JAMA 276:44, 1996
5. Spruance S et al: A large-scale, placebo-controlled, dose-ranging trial of peroral valacyclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 156:1729, 1996
6. Tyring SK et al: A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. Arch Dermatol 134:185, 1988
7. Wald A et al: Frequent genital HSV-2 shedding in immunocompetent women. J Clin Invest 99:1092, 1997